Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.5127
-0.0143 (-2.71%)
At close: Apr 10, 2025, 4:00 PM
0.5200
+0.0073 (1.42%)
After-hours: Apr 10, 2025, 5:53 PM EST
MTNB Market Cap
MTNB has a market cap or net worth of $2.61 million as of April 11, 2025. Its market cap has decreased by -95.87% in one year.
Market Cap
2.61M
Enterprise Value
-5.12M
1-Year Change
-95.87%
Ranking
Category
Stock Price
$0.51
Market Cap Chart
Since March 2, 2017, MTNB's market cap has decreased from $223.50M to $2.61M, a decrease of -98.83%. That is a compound annual growth rate of -42.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2025 | 2.70M | 3.85% |
| Dec 31, 2024 | 2.60M | -94.47% |
| Dec 29, 2023 | 47.00M | -56.64% |
| Dec 30, 2022 | 108.40M | -50.37% |
| Dec 31, 2021 | 218.40M | -19.41% |
| Dec 31, 2020 | 271.00M | -26.64% |
| Dec 31, 2019 | 369.40M | 452.17% |
| Dec 31, 2018 | 66.90M | -37.94% |
| Dec 29, 2017 | 107.80M | -51.77% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.16B |
| UnitedHealth Group | 505.91B |
| Johnson & Johnson | 361.48B |
| AbbVie | 310.76B |
| Novo Nordisk | 281.59B |
| Abbott Laboratories | 214.97B |
| AstraZeneca | 205.27B |
| Merck & Co. | 199.43B |